Education
About Us
Working with TipRanks
Follow Us
Telo Genomics Corp (TSE:TELO)
:TELO
Total Valuation
Telo Genomics Corp has a market cap or net worth of C$5.02M. The enterprise value is C$10.25M.
Market CapC$5.02M
Enterprise ValueC$10.25M
Share Statistics
Telo Genomics Corp has 100,430,470 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding100,430,470
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Telo Genomics Corp’s return on equity (ROE) is -5.28 and return on invested capital (ROIC) is -524.75%.
Return on Equity (ROE)-5.28
Return on Assets (ROA)-2.98
Return on Invested Capital (ROIC)-524.75%
Return on Capital Employed (ROCE)-5.25
Revenue Per Employee0.00
Profits Per Employee-339.84K
Employee Count8
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Telo Genomics Corp is ―. Telo Genomics Corp’s PEG ratio is 0.19.
PE Ratio―
PS Ratio0.00
PB Ratio18.74
Price to Fair Value18.74
Price to FCF-4.14
Price to Operating Cash Flow-1.62
PEG Ratio0.19
Income Statement
In the last 12 months, Telo Genomics Corp had revenue of 0.00 and earned -2.72M in profits. Earnings per share was -0.03.
Revenue0.00
Gross Profit-14.45K
Operating Income-2.70M
Pretax Income-2.72M
Net Income-2.72M
EBITDA-2.69M
Earnings Per Share (EPS)-0.03
Cash Flow
In the last 12 months, operating cash flow was -2.16M and capital expenditures -5.33K, giving a free cash flow of -2.17M billion.
Operating Cash Flow-2.16M
Free Cash Flow-2.17M
Free Cash Flow per Share-0.02
Dividends & Yields
Telo Genomics Corp pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.53
52-Week Price Change-58.33%
50-Day Moving Average0.06
200-Day Moving Average0.08
Relative Strength Index (RSI)48.25
Average Volume (3m)29.30K
Important Dates
Telo Genomics Corp upcoming earnings date is Mar 3, 2026, TBA (Confirmed).
Last Earnings DateNov 25, 2025
Next Earnings DateMar 3, 2026
Ex-Dividend Date―
Financial Position
Telo Genomics Corp as a current ratio of 2.25, with Debt / Equity ratio of 0.00%
Current Ratio2.25
Quick Ratio2.25
Debt to Market Cap0.00
Net Debt to EBITDA0.29
Interest Coverage Ratio-544.29
Taxes
In the past 12 months, Telo Genomics Corp has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
Telo Genomics Corp EV to EBITDA ratio is -3.30, with an EV/FCF ratio of -3.80.
EV to Sales0.00
EV to EBITDA-3.30
EV to Free Cash Flow-3.80
EV to Operating Cash Flow-3.81
Balance Sheet
Telo Genomics Corp has C$486.51K in cash and marketable securities with C$0.00 in debt, giving a net cash position of C$486.51K billion.
Cash & Marketable SecuritiesC$486.51K
Total DebtC$0.00
Net CashC$486.51K
Net Cash Per Share<C$0.01
Tangible Book Value Per Share<C$0.01
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for Telo Genomics Corp is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast19.05%